Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Specialty pharmaceutical and drug delivery company engaged in the research and manufacture of collagen-based technologies for local drug delivery, surgical implants, advanced wound care and oncology. More
Oncology-focused development and commercialisation company More
Active Biotech AB is a Swedish biotech company focusing on the research and development of pharmaceuticals, primarily for the treatment of autoimmune / inflammatory diseases and cancer. More
Proteome Sciences is a global leader in applied proteomics applying high sensitivity proprietary technologies to detect differentially expressed proteins in diseases. More
Debio finances and manages drug development for serious medical conditions More
MBRI is a non-profit research institute focused on the discovery and development of pharmaceutical products in the area of cancer, autoimmune diseases and infectious diseases. More
BioInteractions Ltd is a natural first in solving biocompatible problems to the medical device world. We deliver practical and economical solutions, tailored to the demands of medical device companies More
Theryte develops anti-cancer drugs through a novel mechanism which exploits the cancer cells' own stabilisation machinery. The compounds and targets are available for licensing. More
Your selection
Browse By
- Industry sector
- Bioinformatics
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Adenocarcinoma
- Carcinoid tumour
- Rectal cancer
- Sarcoma
- Squamous cell cancer
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us